Document is current
Any future updates will be listed below
-
Authors
Gertz, Morie A. https://orcid.org/0000-0002-3853-5196
Lacy, Martha Q.
Jacob, Eapen K.
Hogan, William J. https://orcid.org/0000-0002-5841-4105
-
Funding
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (5P50 CA186781-04)
- License Information
-
More Information
Article History
Received: 7 October 2020
Revised: 12 October 2020
Accepted: 2 November 2020
First Online: 11 November 2020
Compliance with ethical standards
:
: MAG reports personal fees from Ionis/Akcea, personal fees from Alnylam, personal fees from Prothena, personal fees from Janssen, grants and personal fees from Spectrum, personal fees from Annexon, personal fees from Appellis, personal fees from Amgen, personal fees from Medscape, personal fees from Physicians Education Resource, personal fees for Data Safety Monitoring board from Abbvie and Celgene, personal fees from Research to Practice, workforce training Sanofi, speaker fees from Teva, Speaker fees from Johnson and Johnson; Speaker fees from Medscape, Speaker fees DAVA oncology; Advisory Board for Pharmacyclics Advisory Board for Proclara; development of educational materials for i3Health. Educational Program development i3Health. Royalties from Springer Publishing. Grant Funding Amyloidosis Foundation; International Waldenstrom Foundation. NCI SPORE MM SPORE 5P50 CA186781-04. Stock Options Aurora Bio.
